NeoPharm Co. Ltd. (092730.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

KRW 371.05B

MomentumView details →

1D Return

−2.94%

YTD Return

+24.93%

RSI (14)

51.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

KRW 371.05B

RSI (14)

51.6

MomentumView details →

1D Return

−2.94%

YTD Return

+24.93%

ProfitabilityView details →

Gross Margin

65.60%

Net Margin

20.65%

EBITDA Margin

27.00%

ROE (TTM)

15.25%

ROA (TTM)

13.55%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

+19.89%

EPS YoY

+20.53%

FCF YoY

+11.01%

Revenue CAGR 3Y

+15.84%

EPS CAGR 3Y

+17.79%

EBITDA YoY

+24.60%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

7.53x

Quick Ratio

6.78x

Div Yield

2.59%

Div Rate

KRW 600.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

148.39B

Net Income (TTM)

30.65B

Op. CF (TTM)

29.43B

Latest newsMore news →

No recent news for 092730.KQ.

Similar companies

Cosmax BTI, Inc.044820.KS The Procter & Gamble CompanyPG VT Co., Ltd.018290.KQ Aekyung Industrial Co., Ltd.018250.KS It'S Hanbul Co., Ltd.226320.KS Able C&C Co., Ltd.078520.KS Find similar companies →

Latest newsMore news →

No recent news for 092730.KQ.